Verano Holdings (VRNO) Receivables - Net (2021 - 2026)
Verano Holdings' (VRNO) quarterly Receivables - Net came in at $32.1 million in Q1 2026, down 19.68% year-on-year from $40.0 million in Q1 2025, and up 3.91% on a QoQ basis from $30.9 million in Q4 2025.
Verano Holdings (VRNO) Receivables - Net (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Receivables - Net data on file, last reported at $32.1 million in Q1 2026.
- On a quarterly basis, Receivables - Net fell 19.68% year-over-year to $32.1 million in Q1 2026; TTM through Mar 2026 was $32.1 million, a 19.68% decrease from a year earlier, with the FY2025 full-year figure at $30.9 million, down 23.18% from the prior year.
- Receivables - Net for Q1 2026 stood at $32.1 million, up from $30.9 million in the prior quarter.
- Over the last five years, Receivables - Net for VRNO reached as high as $46.9 million in Q3 2024 and fell as low as $13.3 million in Q2 2022.
- Historically, Receivables - Net has averaged $31.5 million across 5 years, with a median of $32.3 million in 2025.
- Across the five-year window, Receivables - Net jumped 135.11% in 2023 and plunged 30.85% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $16.6 million in 2022, then soared by 135.11% to $39.0 million in 2023, then advanced by 3.29% to $40.3 million in 2024, then fell by 23.18% to $30.9 million in 2025, then grew by 3.91% to $32.1 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $32.1 million in Q1 2026, $30.9 million in Q4 2025, and $32.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.14 Mn |
| Mar 31, 2026 | 32.14 Mn |
| Dec 31, 2025 | 30.93 Mn |
| Dec 31, 2025 | 30.93 Mn |
| Sep 30, 2025 | 32.46 Mn |
| Sep 30, 2025 | 32.46 Mn |
| Jun 30, 2025 | 30.76 Mn |
| Jun 30, 2025 | 30.76 Mn |
| Mar 31, 2025 | 40.02 Mn |
| Mar 31, 2025 | 40.02 Mn |
| Dec 31, 2024 | 40.26 Mn |
| Dec 31, 2024 | 40.26 Mn |
| Sep 30, 2024 | 46.94 Mn |
| Sep 30, 2024 | 46.94 Mn |
| Jun 30, 2024 | 43.21 Mn |
| Jun 30, 2024 | 43.21 Mn |
| Mar 31, 2024 | 41.93 Mn |
| Mar 31, 2024 | 41.93 Mn |
| Dec 31, 2023 | 38.98 Mn |
| Dec 31, 2023 | 38.98 Mn |